Akzo splits into two independent companies


According to its press release: “Arnhem, the Netherlands, Akzo Nobel has announced that an Extraordinary General Meeting of Shareholders (EGM) is to be held on September 7 and has today published the relevant agenda and shareholders’ circular. At next month’s EGM, shareholders will be asked to give their approval to separate Akzo Nobel into two independent companies — Akzo Nobel, active in coatings and chemicals; and Organon BioSciences (OBS), active in pharmaceuticals. This proposal constitutes a significant change in the identity and nature of Akzo Nobel and therefore requires shareholder approval.

As announced on February 7, 2006, Akzo Nobel intends to separate its Pharma business, preferably through a minority divestment of Organon BioSciences shares, followed by a full separation within two to three years. Positive advice for the separation has already been received from the Central Works Council in the Netherlands, and the next step is to obtain approval from the shareholders to enable the process to proceed. Subject to shareholder approval of the proposed separation, Akzo Nobel plans to divest a minority stake of approximately 20-30% of Organon BioSciences, and have OBS listed on Euronext Amsterdam. This is currently expected to take place by early 2007. The final timing and structure of the separation will depend on market conditions, as well as on developments at Organon BioSciences, including its product pipeline. “We have now reached the point where we can seek shareholder approval for the separation,” said Hans Wijers, Chairman of Akzo Nobel. “The EGM is another step towards achieving our goal of a fully independent Organon BioSciences. Our separation process is on track, we have received a positive advice from our works council, and we look forward to the agreement of our shareholders, which will allow us to move forward to the next phase with the aim of completing the first stage of the separation by early 2007.” Akzo Nobel consulted the Central Works Council in the Netherlands regarding relevant Dutch aspects of the proposed separation. A positive advice was received on July 24.”
Paks II Work 'Rumbling Ahead,' Says Szijjártó Power

Paks II Work 'Rumbling Ahead,' Says Szijjártó

Hungary to Host Next EPC Summit Int’l Relations

Hungary to Host Next EPC Summit

New Tenants at Academia Offices Office Market

New Tenants at Academia Offices

Visitor Numbers, Guest Nights Climb in H1 Tourism

Visitor Numbers, Guest Nights Climb in H1


Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.